Relationship between hypoglycaemia, body mass index and quality of life among patients with type 1 diabetes: Observations from the DEPICT clinical trial programme

Aims To demonstrate the relationships between hypoglycaemia, body mass index (BMI) and quality of life, and to examine the impact of dapagliflozin on patient‐reported treatment satisfaction in patients with type 1 diabetes mellitus (T1DM), using data from the DEPICT (Dapagliflozin Evaluation in Pati...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes, obesity & metabolism obesity & metabolism, 2020-05, Vol.22 (5), p.857-865
Hauptverfasser:	Gordon, Jason, Beresford‐Hulme, Lee, Bennett, Hayley, Tank, Amarjeet, Edmonds, Christopher, McEwan, Phil
Format:	Artikel
Sprache:	eng
Schlagworte:	Body Mass Index Clinical trials dapagliflozin Diabetes Diabetes mellitus (insulin dependent) Diabetes Mellitus, Type 1 - complications Diabetes Mellitus, Type 1 - drug therapy Diabetes Mellitus, Type 1 - epidemiology Hemoglobin Humans hypoglycaemia Hypoglycemia Hypoglycemia - chemically induced Hypoglycemia - epidemiology Hypoglycemia - prevention & control Hypoglycemic Agents - therapeutic use Insulin Patients Quality of Life Questionnaires Regression analysis type 1 diabetes mellitus
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!